These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25084128)

  • 1. Serum cystatin C levels are associated with coronary artery disease and its severity.
    Wang GN; Sun K; Hu DL; Wu HH; Wang XZ; Zhang JS
    Clin Biochem; 2014 Nov; 47(16-17):176-81. PubMed ID: 25084128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate.
    Qing X; Furong W; Yunxia L; Jian Z; Xuping W; Ling G
    Cardiovasc Diabetol; 2012 Sep; 11():108. PubMed ID: 22978689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cystatin C and neutrophil gelatinase-associated lipocalin in predicting the severity of coronary artery disease in diabetic patients.
    Okyay K; Yıldırır A; Çiçek M; Aydınalp A; Müderrisoğlu H
    Anatol J Cardiol; 2016 Oct; 16(10):756-761. PubMed ID: 27182610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of cystatin C with coronary artery disease and its severity.
    Doganer YC; Aydogan U; Aydogdu A; Aparci M; Akbulut H; Nerkiz P; Turker T; Cayci T; Barcin C; Saglam K
    Coron Artery Dis; 2013 Mar; 24(2):119-26. PubMed ID: 23211477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between serum cystatin-c and coronary lesion severity in coronary artery disease patients with a normal glomerular filtration rate.
    Pan J; Sun X; Zhang P; Chen H; Lin J
    J Int Med Res; 2021 Jan; 49(1):300060520985639. PubMed ID: 33435768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of serum cystatin C in predicting coronary artery disease.
    Koc M; Batur MK; Karaarslan O; Abali G
    Cardiol J; 2010; 17(4):374-80. PubMed ID: 20690093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease.
    Wang J; Sim AS; Wang XL; Salonikas C; Moriatis M; Naidoo D; Wilcken DE
    Atherosclerosis; 2008 Apr; 197(2):853-9. PubMed ID: 17826782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cystatin C is associated with early stage coronary atherosclerotic plaque morphology on multidetector computed tomography.
    Imai A; Komatsu S; Ohara T; Kamata T; Yoshida J; Miyaji K; Shimizu Y; Takewa M; Hirayama A; Deshpande GA; Takahashi O; Kodama K
    Atherosclerosis; 2011 Oct; 218(2):350-5. PubMed ID: 21782177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Woitas RP; Kleber ME; Meinitzer A; Grammer TB; Silbernagel G; Pilz S; Tomaschitz A; Weihrauch G; Dobnig H; März W; Scharnagl H
    Atherosclerosis; 2013 Aug; 229(2):541-8. PubMed ID: 23706287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of β2-microglobulin and cystatin C are associated with left atrial size: additional link between the kidney and the heart.
    Liu YS; Wang X; Jiang WD; Huang ZW; Wang YM; Hao L; Xing JL; Wang L; Liu XX; Lounsbury P; Zhang M; Lu QH
    Clin Nephrol; 2013 Sep; 80(3):168-76. PubMed ID: 23849305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cystatin C-based glomerular filtration rate with SYNTAX score in patients with diabetes.
    Yan LQ; Cao XF; Zheng Y; Guo N; Zhao RC; Yu J; Han J; Han LX
    Exp Clin Endocrinol Diabetes; 2013 Aug; 121(8):455-60. PubMed ID: 23864494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study).
    Patel D; Ahmad S; Silverman A; Lindsay J
    Am J Cardiol; 2013 Jun; 111(12):1681-7. PubMed ID: 23499273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced kidney function estimated by cystatin C and clinical outcomes in hypertensive patients with coronary artery disease: association with homocysteine and other cardiovascular risk factors.
    Dzielinska Z; Januszewicz A; Wiecek A; Prejbisz A; Zielinski T; Chudek J; Makowiecka-Ciesla M; Demkow M; Tyczynski P; Januszewicz M; Ruzyllo W; Naruszewicz M
    Kidney Blood Press Res; 2010; 33(2):139-48. PubMed ID: 20516698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study.
    Keller T; Messow CM; Lubos E; Nicaud V; Wild PS; Rupprecht HJ; Bickel C; Tzikas S; Peetz D; Lackner KJ; Tiret L; Münzel TF; Blankenberg S; Schnabel RB
    Eur Heart J; 2009 Feb; 30(3):314-20. PubMed ID: 19153178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of serum cystatin C in predicting coronary artery disease in patients without chronic kidney disease.
    Dandana A; Gammoudi I; Chalghoum A; Chahed H; Addad F; Ferchichi S; Miled A
    J Clin Lab Anal; 2014 May; 28(3):191-7. PubMed ID: 24478035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between serum uric acid level and the severity of coronary artery disease in patients with obstructive coronary artery disease.
    Yu J; Han J; Mao J; Guo L; Gao W
    Chin Med J (Engl); 2014; 127(6):1039-45. PubMed ID: 24622431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of serum cystatin C for prediction of multi-vessel disease by coronary angiography in type 2 diabetes mellitus patients with normal renal function.
    Wang S; Liu Q; Guo F; Zhou X; Shi J; Xie Q
    BMC Cardiovasc Disord; 2020 Apr; 20(1):183. PubMed ID: 32306911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher serum level of Cystatin C: An additional risk factor of CAD.
    Chen Z; Zhang J; Feng J; Zhou G; Jin X; Pan J
    Medicine (Baltimore); 2021 Jan; 100(2):e24269. PubMed ID: 33466214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum free triiodothyronine levels are associated with the presence and severity of coronary artery disease in the euthyroid patients: an observational study.
    Ertaş F; Kaya H; Soydinç MS
    Anadolu Kardiyol Derg; 2012 Nov; 12(7):591-6. PubMed ID: 22877896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations of serum cystatin C and glomerular filtration rate with vascular lesions and severity in acute coronary syndrome.
    Zhang J; Wu X; Gao P; Yan P
    BMC Cardiovasc Disord; 2017 Jan; 17(1):47. PubMed ID: 28143410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.